The S&P/ASX Small Ordinaries Index (ASX:XSO) slipped 25.1 points, or 0.74%, to 3,367.6, extending its five-day decline to 1.68% as weakness across the small-cap sector continued despite a steady ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) finished at 3,505 points, down 6.4 points or 0.18% in the latest session, but remains up 48 points or 1.39% over the past five trading days, reflecting ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and recent financial improvements. FBIO's Q1 2026 saw a dramatic cash increase to $255.8M and net profit ...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a ...

Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large ...

Continuing steady expansion of its ETF lineup, the firm adds three new active equity offerings BALTIMORE, Sept. 17, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader ...

Spero Therapeutics stock is trading higher amid renewed interest in small-cap biotech names, with investors watching its modest market capitalization and recent clinical-stage developments. SPRO, ...

Vaccinex Inc remains a speculative biotech name after recent financing moves and ongoing clinical work in neurology and oncology. What US investors should know about the business model, pipeline ...

IntroductionFortress Biotech (FBIO) is a "holding company" type firm that launches subsidiaries and affiliates called ...

A small float can change the way the market reacts to news. When only a limited number of shares are available for trading, a sudden increase in demand can create a much larger price move than the ...